GlaxoSmithKline has settled the tax dispute with the Internal Revenue Service (IRS) for $3.1 billion, including federal, state and local taxes, interest and the benefit of tax relief on payments already made. The settlement covers a transfer pricing tax dispute dating from 1989 through 2005 that was to be decided by a trial scheduled for February 2007. According to a company statement, the final payment fell within a $4.1 billion provision made by the company for tax liabilities. The compan...